Pfizer Inc. (BVMF:PFIZ34)

Market Cap	741.31B
Revenue (ttm)	360.40B
Net Income (ttm)	45.48B
Shares Out	n/a
EPS (ttm)	7.98
PE Ratio	16.30
Forward PE	8.36
Dividend	1.65 (5.08%)
Ex-Dividend Date	Jul 24, 2025

Volume	4,334
Average Volume	7,535
Open	32.50
Previous Close	32.42
Day's Range	32.09 - 32.64
52-Week Range	30.84 - 44.90
Beta	0.50
RSI	36.67
Earnings Date	Aug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: PFIZ34

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD